358 related articles for article (PubMed ID: 36741415)
1. The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy.
Lu C; Liu Y; Ali NM; Zhang B; Cui X
Front Immunol; 2022; 13():1039260. PubMed ID: 36741415
[TBL] [Abstract][Full Text] [Related]
2. Innate Immune Cells in the Esophageal Tumor Microenvironment.
Cui K; Hu S; Mei X; Cheng M
Front Immunol; 2021; 12():654731. PubMed ID: 33995371
[TBL] [Abstract][Full Text] [Related]
3. The Tumor Microenvironment Innately Modulates Cancer Progression.
Hinshaw DC; Shevde LA
Cancer Res; 2019 Sep; 79(18):4557-4566. PubMed ID: 31350295
[TBL] [Abstract][Full Text] [Related]
4. Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME).
Sadeghi M; Dehnavi S; Sharifat M; Amiri AM; Khodadadi A
Heliyon; 2024 Mar; 10(5):e27480. PubMed ID: 38463798
[TBL] [Abstract][Full Text] [Related]
5. Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.
Albini A; Bruno A; Noonan DM; Mortara L
Front Immunol; 2018; 9():527. PubMed ID: 29675018
[TBL] [Abstract][Full Text] [Related]
6. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Gaggero S; Witt K; Carlsten M; Mitra S
Front Immunol; 2020; 11():621225. PubMed ID: 33584718
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.
Carnevalli LS; Ghadially H; Barry ST
Front Immunol; 2021; 12():633685. PubMed ID: 33953710
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles Targeting Innate Immune Cells in Tumor Microenvironment.
Jang H; Kim EH; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576180
[TBL] [Abstract][Full Text] [Related]
9. Innate lymphoid cells and cancer: Role in tumor progression and inhibition.
Yuan X; Rasul F; Nashan B; Sun C
Eur J Immunol; 2021 Sep; 51(9):2188-2205. PubMed ID: 34189723
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression.
Wang S; Sun J; Dastgheyb RM; Li Z
Front Immunol; 2022; 13():1045624. PubMed ID: 36405712
[TBL] [Abstract][Full Text] [Related]
11. Innate Immunity in Cancer Biology and Therapy.
Zhang Y; Xue W; Xu C; Nan Y; Mei S; Ju D; Wang S; Zhang X
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37510993
[TBL] [Abstract][Full Text] [Related]
12. Autophagy, the innate immune response and cancer.
Gerada C; Ryan KM
Mol Oncol; 2020 Sep; 14(9):1913-1929. PubMed ID: 32745353
[TBL] [Abstract][Full Text] [Related]
13. Immune and Inflammatory Cells in Thyroid Cancer Microenvironment.
Ferrari SM; Fallahi P; Galdiero MR; Ruffilli I; Elia G; Ragusa F; Paparo SR; Patrizio A; Mazzi V; Varricchi G; Marone G; Antonelli A
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500315
[TBL] [Abstract][Full Text] [Related]
14. The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors.
Baci D; Bosi A; Gallazzi M; Rizzi M; Noonan DM; Poggi A; Bruno A; Mortara L
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354198
[TBL] [Abstract][Full Text] [Related]
15. Innate immunity in cutaneous melanoma.
Mignogna C; Scali E; Camastra C; Presta I; Zeppa P; Barni T; Donato G; Bottoni U; Di Vito A
Clin Exp Dermatol; 2017 Apr; 42(3):243-250. PubMed ID: 28052512
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy.
Zhang W; Zhao Z; Li F
Mol Immunol; 2022 Apr; 144():58-70. PubMed ID: 35203022
[TBL] [Abstract][Full Text] [Related]
17. Modulating the innate immune activity in murine tumor microenvironment by a combination of inducer molecules attached to microparticles.
Shahar E; Gorodetsky R; Aizenshtein E; Lalush L; Pitcovski J
Cancer Immunol Immunother; 2015 Sep; 64(9):1137-49. PubMed ID: 26031575
[TBL] [Abstract][Full Text] [Related]
18. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
[TBL] [Abstract][Full Text] [Related]
19. Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers.
Guo X; Sun M; Yang P; Meng X; Liu R
Eur J Pharmacol; 2023 Dec; 960():176103. PubMed ID: 37852570
[TBL] [Abstract][Full Text] [Related]
20. Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.
Wu D
Adv Exp Med Biol; 2017; 1011():211-223. PubMed ID: 28875492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
